|
Volumn 14, Issue 7 SUPPL. 4, 2000, Pages 7-14
|
Advances in treatment of inoperable NSGLG: Gemcitabine doublets-A promising alternative
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
CARBOPLATIN;
CISPLATIN;
DEOXYCYTIDINE;
DOCETAXEL;
DRUG DERIVATIVE;
GEMCITABINE;
NAVELBINE;
PACLITAXEL;
TAXANE;
TAXOID;
VINBLASTINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRIDGED COMPOUNDS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
TAXOIDS;
VINBLASTINE;
|
EID: 0034222748
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (5)
|